Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis

References

• Tyagi AM, Srivastava K, Mansoori MN, et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One 2012;7:e44552
   PubMed Web of Science ®Google Scholar
• DeSelm CJ, Takahata Y, Warren J, et al. IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem 2012;113:2895–902
   PubMedGoogle Scholar
• Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305–11
   PubMed Web of Science ®Google Scholar
• Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994;9:883–90
   PubMed Web of Science ®Google Scholar
• Lacey DL, Erdmann JM, Teitelbaum SL, et al. Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995;136:2367–76
   PubMed Web of Science ®Google Scholar
• Bendixen AC, Shevde NK, Dienger KM, et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci U S A 2001;98:2443–8
   PubMed Web of Science ®Google Scholar
• Kamel MS, Sugiyama E, Shinoda K, et al. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Biochem Biophys Res Commun 2005;329:839–45
   PubMedGoogle Scholar
• Miossec P, Chomarat P, Dechanet J, et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994;37:1715–22
   PubMedGoogle Scholar
• Riancho JA, Zarrabeitia MT, Gonzalez-Macias J. Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun 1993;196:678–85
   PubMedGoogle Scholar
• Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005;208:181–93
   PubMedGoogle Scholar
• Xu Z, Hurchla MA, Deng H, et al. Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases. J Biol Chem 2009;284:4658–66
   PubMedGoogle Scholar
• Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007;117:122–32
   PubMed Web of Science ®Google Scholar
• Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005;208:154–68
   PubMed Web of Science ®Google Scholar
• Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006;116:1186–94
   PubMed Web of Science ®Google Scholar
• Morita Y, Yamamura M, Kawashima M, et al. Flow cytometric single-cell analysis of cytokine production by CD4 + T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1669–76
   PubMed Web of Science ®Google Scholar
• Steiner G, Tohidast-Akrad M, Witzmann G, et al. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 1999;38:202–13
   PubMed Web of Science ®Google Scholar
• Partsch G, Wagner E, Leeb BF, et al. T cell derived cytokines in psoriatic arthritis synovial fluids. Ann Rheum Dis 1998;57:691–3
   PubMed Web of Science ®Google Scholar
• Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 2013;342:1094–8
   PubMed Web of Science ®Google Scholar
• Neumark DE, Sheon N, Palefsky J. Investigating motivations for participation in an anal cancer screening trial (IMPACT). Sex Health 2013;10:583–4
   Google Scholar
• Marsh K, Snow RW. 30 years of science and technology: the example of malaria. Lancet 1997;349(Suppl 3):S1–S2 . pii: http://dx.doi.org/10.1016/S0140-6736(97)90063-5
   PubMedGoogle Scholar
• Van Vlasselaer P, Borremans B, van Gorp U, et al. Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cells. J Cell Biol 1994;124:569–77
   PubMed Web of Science ®Google Scholar
• Owens JM, Gallagher AC, Chambers TJ. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 1996;157:936–40
   PubMedGoogle Scholar
• Molnar I, Bohaty I, Somogyine-Vari E. High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency. Menopause 2014;21:749–52
   PubMed Web of Science ®Google Scholar
• Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008;41:92–104
   PubMed Web of Science ®Google Scholar
• Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007;8:247–56
   PubMed Web of Science ®Google Scholar
• Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006;281:35603–7
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673–82
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942–9
   PubMed Web of Science ®Google Scholar
• Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423–30
   PubMed Web of Science ®Google Scholar
• Li X, Yuan FL, Lu WG, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 2010;397:131–5
   PubMed Web of Science ®Google Scholar
• Yago T, Nanke Y, Ichikawa N, et al. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem 2009;108:947–55
   PubMed Web of Science ®Google Scholar
• Ji JD, Park-Min KH, Shen Z, et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 2009;183:7223–33
   PubMed Web of Science ®Google Scholar
• Duque G, Huang DC, Macoritto M, et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009;27:550–8
   PubMed Web of Science ®Google Scholar
• Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem 2006;98:706–14
   PubMed Web of Science ®Google Scholar
• Sir Cooper A. A treatise on dislocations and on fractures of the joints: fractures of the neck of the thigh-bone. 1823. Clin Orthop Relat Res 2007;458:6–7
   PubMedGoogle Scholar
• Ershler WB, Harman SM, Keller ET. Immunologic aspects of osteoporosis. Dev Comp Immunol 1997;21:487–99
   PubMedGoogle Scholar
• Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol 2007;8:4
   PubMed Web of Science ®Google Scholar
• Gur A, Denli A, Nas K, et al. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int 2002;22:194–8
   PubMed Web of Science ®Google Scholar
• Gumus P, Buduneli E, Biyikoglu B, et al. Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease. Arch Oral Biol 2013;58:1302–8
   PubMedGoogle Scholar
• Furuta I, Kobayashi N, Fujino T, et al. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 2004;74:509–15
   PubMedGoogle Scholar
• Whiteside TL. Cytokine assays. Biotechniques 2002; Suppl:4–8, 10, 12–15
   Google Scholar
• Czerny B, Kaminski A, Kurzawski M, et al. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2010;149:82–5
   PubMedGoogle Scholar
• Park BL, Han IK, Lee HS, et al. Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J Biochem Mol Biol 2004;37:691–9
   PubMedGoogle Scholar